For corresponding authors from organizations that hold a current online or combined subscription to Biochemical Society Transactions at the time that their manuscripts have been accepted for publication the fee for this option is £1500; US$3000; €2200.
For an author based at an organization that does not have a current subscription the fee is: £1750; US$3500; €2590.Is this the true cost of publishing my article?
No, this is currently being heavily subsidized by the traditional reader-pays (subscription) model. As more authors opt to pre-pay for their articles, the pre-payment fee is likely to increase to enable us to recover our costs, make a surplus for future investment, and to allow the Biochemical Society to continue to provide support for the research community. There will be a concomitant decrease in the subscription as the amount of freely accessible content increases significantly.Will I get a discount if my organization has a current subscription?
Yes, if your organization has an active subscription.How can I find out if my institution has a current combined or online-only subscription?
You can check whether your institution has an active online subscription to Biochemical Society Transactions by clicking on the following link (you must use an institutional computer): http://www.portlandpress.com/ppl/subs_sirius.asp?jnl=BSTWill an institutional print subscription to Biochemical Society Transactions entitle me to the discounted fee?
No, only a current online only or combined subscription will entitle you to the discount.Will I get a discount if I am a member of the Biochemical Society?
Yes, if the corresponding author has been a Full or Early Career member of the Society for at least 2 years.What if I cannot pay?
If you cannot afford to pre-pay for access, your article will be available via the reader-pays (subscription) model.Will publication of my manuscript be delayed if payment is not received by the time it is accepted for publication?
Biochemical Society Transactions constantly endeavours to keep handling times to the minimum. The processing of your article will not be delayed in any way at any stage owing to a failure to pay; however, the Version of Record (VoR) of your accepted article will not be made freely available until payment has been processed, but it will be available via the reader-pays (subscription) option.How will readers know which articles have pre-paid access?
Such articles will be clearly identifiable via the Opt2Pay icon in the Table of Contents and on the article itself.How will Opt2Pay affect my copyright?
Articles of authors who opt to pre-pay for access will be made available under the Creative Commons Attribution Licence (CC-BY), which permits unrestricted use, distribution and reproduction in any medium, provided the work is cited appropriately.How may authors use Opt2Pay articles published in Biochemical Society Transactions?
The Opt2Pay scheme entitles you and your co-authors to post the PDF version of your Version of Record (VoR), for non-commercial purposes, on your own or institutional website, or to free public servers in the relevant subject area, in whole or in part according to the terms of the licence. This is provided you include a link to the published version of the article on the Biochemical Society Transactions website and that the Journal, the Biochemical Society and Portland Press are given the correct attributions.
Portland Press Limited will undertake to post all pre-paid articles to PubMed Central, as a service to its authors on receipt of payment, and permit their inclusion in PubMed Central mirror sites. You will be notified of the PMCID for your article by email.What happens to my copyright if I do not pre-pay for free access?
Portland Press Limited and the Biochemical Society do not require authors who opt not to pay to transfer their copyright, but do require the grant of an exclusive licence to publish. The copyright in the article will remain with the author(s), and Portland Press Limited will acknowledge this in the copyright line which appears on the article.
All authors are free to use their Accepted Manuscript (AM) for self-archiving on their own website or in their institutional repository, after 6 months, provided it is made clear that this is not the Version of Record (VoR), and that a link is provided to the Version of Record (VoR) on the Biochemical Society Transactions website and that the Journal, the Biochemical Society and Portland Press are given the correct attributions.
Biochemical Society Transactions is compliant with the NIH mandate: authors may deposit their Accepted Manuscript (AM) in PubMed Central immediately on submission with an embargo for public release of 12 months from the date of print publication.What about authors from developing countries?
Portland Press supports HINARI run by the World Health Organization and part of the Research4Life partnership. This means that low-income countries can already obtain free (or very low-cost) access to its journals.
Online-only prices of journals published by Portland Press will be adjusted in the future to reflect any significant increase in the number of articles where access has been pre-paid by the authors and/or their funding bodies.
∗For definitions of journal article versions, see the Recommended Practice of the National Information Standards Organization in Partnership with the Association of Learned and Professional Society Publishers.